Smartest Doc
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors
International Journal of STD & AIDS, 08/10/2012
Bucciardini R et al. – Even if they cannot exclude the presence of pre–existing minority resistant variants not captured by genotypic tests, the lack of baseline predictors of failure suggests the need to monitor patients closely during follow up for other factors, such as potential drug interactions and reduced levels of adherence, which may favour virological failure.
